Events
Filter by:
Biomedical Discussion Group: Dr. Diego L. Guarin, Postdoctoral Researcher Toronto Rehabilitation Institute and University of Toronto
Dr. Diego L. Guarin
Postdoctoral Researcher Toronto Rehabilitation Institute and University of Toronto
Fellow of the Michael J. Fox Foundation for Parkinson's Research
CBB/WIN Industry Seminar: Dr. Ronald Li - Advances of Stem Cell Biotechnology for Development of Bio-artificial Human Heart
Please join the Centre for Bioengineering and Biotechnology (CBB) and the Waterloo Institute for Nanotechnology (WIN) on Monday September 30, 2019 for a guest lecture by Dr. Ronald Li, Co-founder and CEO of Novoheart speaking on “Advances of Stem Cell Biotechnology for Development of Bio-artificial Human Heart” [Poster ]
CBB - Visiting Institute Presentation: Leading Innovation for a Universal Public Healthcare System: The Case of FIOCRUZ in Brazil
CBB - Visiting Institute Presentation: MEDTEQ Innovation for Health, Quebec
CREATE - Clinical Evaluations Model: Ethical Research with Human Participants
CREATE - Interdisciplinary Collaboration Research in Regenerative Medicine
CBB CREATE Series: Interdisciplinary collaboration research in regenerative medicine
Biomedical Discussion Group: Dr. Clayton Radke - Solute Partitioning and Diffusion in Hydrogels: Fundamentals of Drug and Comfort-Agent Delivery
Dr. Clayton (Clay) J. Radke
Professor of Chemical and Biomolecular Engineering and Vision Science at the University California (Berkeley)
Title: Solute Partitioning and Diffusion in Hydrogels: Fundamentals of Drug and Comfort-Agent Delivery
Health Canada Regulatory Insights Workshop
CREATE - Ethical by Design Workshop
CBB CREATE Series: Ethical By Design Workshop
Speaker: Dr. Jen Boger, Assistant Professor, SYDE, University of Waterloo.
Description:
There is an accelerating trend toward the necessity of ethical technology, system, and program development as well as for the people who are making these products be responsible for what they create. How can developers/designers actively engage in responsible innovation, especially considering the diversity and complexity of related applications, contexts, and values?